News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
330,954 Results
Type
Article (17949)
Company Profile (312)
Press Release (312685)
Multimedia
Podcasts (84)
Webinars (12)
Section
Business (95465)
Career Advice (220)
Deals (16837)
Drug Delivery (48)
Drug Development (57309)
Employer Resources (41)
FDA (6835)
Job Trends (6462)
News (171491)
Policy (11997)
Tag
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (998)
Accelerated approval (20)
Adcomms (14)
Allergies (85)
Alliances (24658)
ALS (139)
Alzheimer's disease (1152)
Antibody-drug conjugate (ADC) (268)
Approvals (7079)
Artificial intelligence (290)
Autoimmune disease (127)
Automation (10)
Bankruptcy (121)
Best Places to Work (5559)
BIOSECURE Act (7)
Biosimilars (127)
Biotechnology (238)
Bladder cancer (113)
Brain cancer (48)
Breast cancer (396)
Cancer (3534)
Cardiovascular disease (271)
Career advice (202)
Career pathing (10)
CAR-T (243)
CDC (6)
Cell therapy (622)
Cervical cancer (19)
Clinical research (49516)
Collaboration (1254)
Company closure (3)
Compensation (735)
Complete response letters (39)
COVID-19 (1242)
CRISPR (90)
C-suite (597)
Cystic fibrosis (130)
Data (4814)
Decentralized trials (1)
Denatured (14)
Depression (101)
Diabetes (296)
Diagnostics (2109)
Digital health (13)
Diversity (6)
Diversity, equity & inclusion (10)
Drug discovery (205)
Drug pricing (61)
Drug shortages (5)
Duchenne muscular dystrophy (219)
Earnings (40456)
Editorial (26)
Employer branding (8)
Employer resources (38)
Events (60899)
Executive appointments (676)
FDA (8819)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (23)
Funding (1079)
Gene editing (194)
Generative AI (25)
Gene therapy (522)
GLP-1 (632)
Government (1303)
Grass and pollen (3)
Guidances (222)
Healthcare (7738)
HIV (30)
Huntington's disease (44)
IgA nephropathy (82)
Immunology and inflammation (215)
Immuno-oncology (41)
Indications (66)
Infectious disease (1385)
Inflammatory bowel disease (162)
Inflation Reduction Act (10)
Influenza (53)
Intellectual property (181)
Interviews (23)
IPO (9039)
IRA (21)
Job creations (1229)
Job search strategy (175)
JPM (48)
Kidney cancer (9)
Labor market (27)
Layoffs (363)
Leadership (14)
Legal (1735)
Liver cancer (57)
Longevity (11)
Lung cancer (478)
Lymphoma (292)
Machine learning (28)
Management (11)
Manufacturing (438)
MASH (143)
Medical device (3229)
Medtech (3249)
Mergers & acquisitions (8528)
Metabolic disorders (858)
Multiple sclerosis (122)
NASH (14)
Neurodegenerative disease (254)
Neuropsychiatric disorders (80)
Neuroscience (2151)
Neurotech (1)
NextGen: Class of 2026 (2325)
Non-profit (990)
Now hiring (29)
Obesity (405)
Opinion (157)
Ovarian cancer (145)
Pain (111)
Pancreatic cancer (174)
Parkinson's disease (242)
Partnered (15)
Patents (343)
Patient recruitment (355)
Peanut (45)
People (30562)
Pharmaceutical (49)
Pharmacy benefit managers (8)
Phase I (17124)
Phase II (22841)
Phase III (15091)
Pipeline (3749)
Policy (105)
Postmarket research (960)
Preclinical (7078)
Press Release (32)
Prostate cancer (161)
Psychedelics (50)
Radiopharmaceuticals (270)
Rare diseases (682)
Real estate (1784)
Recruiting (17)
Regulatory (11639)
Reports (20)
Research institute (1058)
Resumes & cover letters (25)
Rett syndrome (23)
RNA editing (20)
RSV (33)
Schizophrenia (135)
Series A (196)
Series B (144)
Service/supplier (2)
Sickle cell disease (88)
Special edition (18)
Spinal muscular atrophy (126)
Sponsored (17)
Startups (2238)
State (1)
Stomach cancer (5)
Supply chain (40)
Tariffs (26)
The Weekly (69)
Vaccines (484)
Venture capital (76)
Weight loss (227)
Women's health (39)
Worklife (2)
Date
Today (28)
Last 7 days (301)
Last 30 days (1547)
Last 365 days (20974)
2026 (1547)
2025 (21182)
2024 (23712)
2023 (26007)
2022 (31456)
2021 (32380)
2020 (27256)
2019 (19206)
2018 (14147)
2017 (16684)
2016 (14150)
2015 (17049)
2014 (12164)
2013 (8702)
2012 (8919)
2011 (9166)
2010 (8903)
Location
Africa (203)
Alabama (67)
Alaska (2)
Arizona (81)
Arkansas (5)
Asia (21898)
Australia (3761)
California (8070)
Canada (2022)
China (879)
Colorado (257)
Connecticut (309)
Delaware (256)
Europe (47879)
Florida (986)
Georgia (237)
Hawaii (2)
Idaho (19)
Illinois (437)
India (38)
Indiana (219)
Iowa (10)
Japan (300)
Kansas (81)
Kentucky (9)
Louisiana (8)
Maine (11)
Maryland (864)
Massachusetts (6246)
Michigan (123)
Minnesota (261)
Mississippi (3)
Missouri (43)
Montana (18)
Nebraska (5)
Nevada (44)
New Hampshire (21)
New Jersey (2056)
New Mexico (16)
New York (2033)
North Carolina (900)
North Dakota (6)
Northern California (4044)
Ohio (188)
Oklahoma (13)
Oregon (25)
Pennsylvania (1388)
Puerto Rico (11)
Rhode Island (26)
South America (279)
South Carolina (13)
Southern California (3110)
Tennessee (49)
Texas (1049)
United States (26565)
Utah (128)
Virginia (164)
Washington D.C. (44)
Washington State (635)
West Virginia (1)
Wisconsin (79)
Wyoming (1)
330,954 Results for "pipeline therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Akebia Therapeutics Announces Corporate Updates and 2026 Pipeline Outlook
January 12, 2026
·
13 min read
Press Releases
Neumora Therapeutics Highlights 2026 Pipeline Strategy and Anticipated Upcoming Milestones
January 5, 2026
·
6 min read
Press Releases
Werewolf Therapeutics Announces Pipeline and Business Updates
December 19, 2025
·
10 min read
Press Releases
AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE
January 7, 2026
·
8 min read
Press Releases
Defence Therapeutics Expands Collaboration with Canadian Nuclear Laboratories to Accelerate Its Proprietary Radiopharmaceutical Pipeline
January 28, 2026
·
5 min read
Press Releases
Ipsen completes acquisition of ImCheck Therapeutics, expanding oncology pipeline
December 16, 2025
·
4 min read
Press Releases
Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout
December 16, 2025
·
5 min read
Press Releases
Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates
December 24, 2025
·
3 min read
Press Releases
Hoth Therapeutics Expands Oncology Pipeline with Dual Patent Filings Establishing Novel Oncology Dermatology IP Platform
January 5, 2026
·
6 min read
Press Releases
TRexBio Closes $50 Million Financing to Support a Growing Clinical-Stage Immunology Pipeline of Tissue-Targeted Treg Therapeutics
January 27, 2026
·
4 min read
1 of 33,096
Next
